208725 Calphostin C, Cladosporium cladosporioides - CAS 121263-19-2 - Calbiochem

208725
가격을 검색할 수 없습니다
Minimum Quantity needs to be mulitiple of
가격 문의 추가 정보
()이 할인됨
 
가격 문의
재고 없음재고 없음
예상 출고 가능일 
단종품
제한된 수량 가능
재고여부 확인
    Remaining: will advise
      Remaining: will advise
      추천사항
      고객 서비스로 문의
      Contact Customer Service
      가격 및 재고 조회

      개요

      Replacement Information

      주요 사양표

      Empirical FormulaCAS #
      C₄₄H₃₈O₁₄ 121263-19-2

      가격 및 재고여부

      카탈로그 번호 재고 정보패킹 포장 단위 가격(VAT 별도) 수량
      208725-100UGCN
      재고 정보 검색...
      재고 없음재고 없음
      예상 출고 가능일 
      단종품
      제한된 수량 가능
      재고여부 확인
        Remaining: will advise
          Remaining: will advise
          추천사항
          고객 서비스로 문의
          Contact Customer Service

          Plastic ampoule 100 μg
          가격 검색...
          가격을 검색할 수 없습니다
          Minimum Quantity needs to be mulitiple of
          가격 문의 추가 정보
          ()이 할인됨
           
          가격 문의
          208725-50UGCN
          재고 정보 검색...
          재고 없음재고 없음
          예상 출고 가능일 
          단종품
          제한된 수량 가능
          재고여부 확인
            Remaining: will advise
              Remaining: will advise
              추천사항
              고객 서비스로 문의
              Contact Customer Service

              Plastic ampoule 50 μg
              가격 검색...
              가격을 검색할 수 없습니다
              Minimum Quantity needs to be mulitiple of
              가격 문의 추가 정보
              ()이 할인됨
               
              가격 문의
              Description
              OverviewA cell permeable, highly specific inhibitor of protein kinase C (IC50 = 50 nM) that interacts with the protein’s regulatory domain by competing at the binding site of diacylglycerol and phorbol esters. Does not compete with Ca2+ or phospholipids. At higher concentrations inhibits myosin light chain kinase (IC50 > 5 µM), protein kinase A (IC50 > 50 µM), protein kinase G (IC50 > 25 µM), and p60v-src (IC50 > 50 µM). Induces apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells. Requires brief exposure to light for activation.
              Catalogue Number208725
              Brand Family Calbiochem®
              SynonymsUCN-1028c
              References
              ReferencesJarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
              Svetlov, S., and Nigami, S. 1993. Biochim. Biophys. Acta 1177, 75.
              Gopalakrishna, R., et al. 1992. FEBS Lett. 314, 149.
              Shimamato, H., et al. 1992. Br. J. Pharmacol. 107, 282.
              Bruns, R.F., et al. 1991. Biochem. Biophys. Res. Commun. 176, 288.
              Tamaoki, T., et al. 1990. Biotechnology 8, 732.
              Kobayashi, E., et al. 1989. Biochem. Biophys. Res. Commun. 159, 548.
              Product Information
              CAS number121263-19-2
              ATP CompetitiveN
              FormLight brown lyophilized solid
              Hill FormulaC₄₄H₃₈O₁₄
              Chemical formulaC₄₄H₃₈O₁₄
              ReversibleN
              Structure formula ImageStructure formula Image
              Quality LevelMQ100
              Applications
              Biological Information
              Primary TargetPKC
              Primary Target IC<sub>50</sub>50 nM against protein kinase C
              Purity≥95% by HPLC
              Physicochemical Information
              Cell permeableY
              Dimensions
              Materials Information
              Toxicological Information
              Safety Information according to GHS
              Safety Information
              Product Usage Statements
              Storage and Shipping Information
              Ship Code Ambient Temperature Only
              Toxicity Standard Handling
              Storage +2°C to +8°C
              Protect from Light Protect from light
              Do not freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
              Packaging Information
              Transport Information
              Supplemental Information
              Specifications

              Documentation

              Calphostin C, Cladosporium cladosporioides - CAS 121263-19-2 - Calbiochem MSDS

              타이틀

              물질안전보건자료(MSDS) 

              Calphostin C, Cladosporium cladosporioides - CAS 121263-19-2 - Calbiochem Certificates of Analysis

              TitleLot Number
              208725

              References

              참고문헌 보기
              Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
              Svetlov, S., and Nigami, S. 1993. Biochim. Biophys. Acta 1177, 75.
              Gopalakrishna, R., et al. 1992. FEBS Lett. 314, 149.
              Shimamato, H., et al. 1992. Br. J. Pharmacol. 107, 282.
              Bruns, R.F., et al. 1991. Biochem. Biophys. Res. Commun. 176, 288.
              Tamaoki, T., et al. 1990. Biotechnology 8, 732.
              Kobayashi, E., et al. 1989. Biochem. Biophys. Res. Commun. 159, 548.

              Brochure

              Title
              Caspases and other Apoptosis Related Tools Brochure

              Citations

              타이틀
            • Martha E. O'Donnnell, et al. (2005) Arginine Vasopressin Stimulation of Cerebral Microvascular Endothelial Cell Na-K-Cl Cotransporter Activity is V1 Receptor and [Ca] Dependent. American Journal of Physiology Cell Physiology 289, C283-C292.
            • Yi Dai, et al. (2004) Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. Journal of Neuroscience 24, 4293-4299.
            • Data Sheet

              Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

              Revision28-May-2008 RFH
              SynonymsUCN-1028c
              DescriptionCell-permeable, highly specific inhibitor of protein kinase C (IC50 = 50 nM) that interacts with the protein's regulatory domain by competing at the binding site of diacylglycerol and phorbol esters. At higher concentrations inhibits myosin light chain kinase (IC50 > 5 µM), protein kinase A (IC50 > 50 µM), protein kinase G (IC50 > 25 µM), and p60v-src protein tyrosine kinase (IC50 > 50 µM). Does not compete with Ca2+ or phospholipids. Also induces apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells. Inhibition of PKC is dependent on exposure to light in cell-free systems. Ordinary fluorescent light is sufficient for full activation.
              FormLight brown lyophilized solid
              CAS number121263-19-2
              Chemical formulaC₄₄H₃₈O₁₄
              Structure formulaStructure formula
              Purity≥95% by HPLC
              SolubilityDMSO (1 mg/ml) or Ethanol
              Storage +2°C to +8°C
              Protect from light
              Do Not Freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
              Toxicity Standard Handling
              ReferencesJarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
              Svetlov, S., and Nigami, S. 1993. Biochim. Biophys. Acta 1177, 75.
              Gopalakrishna, R., et al. 1992. FEBS Lett. 314, 149.
              Shimamato, H., et al. 1992. Br. J. Pharmacol. 107, 282.
              Bruns, R.F., et al. 1991. Biochem. Biophys. Res. Commun. 176, 288.
              Tamaoki, T., et al. 1990. Biotechnology 8, 732.
              Kobayashi, E., et al. 1989. Biochem. Biophys. Res. Commun. 159, 548.
              Citation
            • Martha E. O'Donnnell, et al. (2005) Arginine Vasopressin Stimulation of Cerebral Microvascular Endothelial Cell Na-K-Cl Cotransporter Activity is V1 Receptor and [Ca] Dependent. American Journal of Physiology Cell Physiology 289, C283-C292.
            • Yi Dai, et al. (2004) Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. Journal of Neuroscience 24, 4293-4299.